Back to Search
Start Over
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients with Locally Advanced or Metastatic/Recurrent EGFR T790M Mutated NSCLC: A Phase IIb Study
- Source :
- SSRN Electronic Journal.
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
Details
- ISSN :
- 15565068
- Database :
- OpenAIRE
- Journal :
- SSRN Electronic Journal
- Accession number :
- edsair.doi...........751976f78fc64167a4a4ede670badcb6
- Full Text :
- https://doi.org/10.2139/ssrn.4106843